Enzymotec granted new US, Australian patents

Enzymotec granted new US, Australian patents

Enzymotec strengthens its global position in the omega-3 market with newly granted "master patents" for phospholipid-based products.

Enzymotec Ltd., a developer, manufacturer and marketer of innovative bioactive lipid ingredients, announced that it was granted patents by the U.S. Patent and Trademark Office and by IP Australia. The newly granted patents cover certain phospholipid compositions which include long chain polyunsaturated fatty acids and are relevant for several of Enzymotec's products such as krill oil and other omega-3 products.

Enzymotec's patents are like master patents in that they cover wide variety of phospholipid based compositions that include long chain poly-unsaturated fatty acids, and are pertinent to a number of Enzymotec's products, such as the K•REAL® krill oil products and additional advanced phospholipid products . These additions to Enzymotec's broad patent portfolio are the result of the Company’s efforts to continually maintain and reinforce the protection of its products.

Dr. Ariel Katz, president and chief executive officer of Enzymotec, commented, “As experts in specialty phospholipid-based products, we are excited by the further strengthening of our portfolio of intellectual property with these important patents. Our products are strong leaders in the market, driven by our specialized technologies and supported with an enforceable patent portfolio. These new patents are demonstrative of our commitment to innovation and provide our customers with exceptional ingredients of the highest quality."

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.